FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3136306228> ?p ?o ?g. }

• W3136306228 abstract "Abstract Background Breast cancer is a leading malignant tumor which causes deaths among women, and metastasis is the primary cause for mortality in breast cancer. Due to the involvement of many regulatory molecules and signaling pathways, the occurrence and development process of metastasis needs to be further studied. MicroRNAs (miRNAs) are ubiquitously expressed small non-coding RNAs that have been shown to play an important role in the diagnosis and treatment of many diseases, as well as constituting an attractive candidate to control metastasis. In this study, we tried to uncover the mechanism of GBK in impairing breast cancer cell invasion and metastasis. Methods We treated cancer cells with GBK or not, found its target miRNA by analyzed miRNA transcriptional changes and the miRNA target genes by performed with the QT-PCR and Western Blot. The proliferation of breast cancer cells in vitro and in vivo under combination treatment with GBK and DDP was measured by CCK-8 kit and the nude mice tumor formation experiment. Results We found tumor suppressor miR-31 was a main target of GBK. GBK treatment affected the epigenetic modification at CpG sites by downregulating DNA methyltransferases, thus the methylation levels at CpG of lncRNA LOC554202 decreased significantly, and in turn upregulating of both miR-31 and its host gene LOC554202 in breast cancer cells. We also observed significant inhibition of miR-31 target genes under GBK stimulation, including RhoA , WAVE3 and SATB2 , which all closely related to cancer cell invasion, migration and proliferation. Furthermore, we revealed that combination treatment with GBK and DDP had synergistic and dose reduction potential in inhibiting the proliferation of breast cancer cells in vitro and in vivo , especially in TNBC. Conclusion This study further analyzes the target and underlying mechanism of GBK in inhibiting breast cancer migration and invasion, and provides theoretical support for the development of GBK as an auxiliary drug for clinical treatment." @default.
• W3136306228 created "2021-03-29" @default.
• W3136306228 creator A5016820076 @default.
• W3136306228 creator A5038407555 @default.
• W3136306228 creator A5045268311 @default.
• W3136306228 creator A5054528305 @default.
• W3136306228 creator A5078713137 @default.
• W3136306228 date "2021-03-19" @default.
• W3136306228 modified "2023-09-27" @default.
• W3136306228 title "The antihyperlipidemic drug Potassium Piperate impairs migration and tumorgenesis of breast cancer cells via upregulation of miR-31" @default.
• W3136306228 doi "https://doi.org/10.21203/rs.3.rs-290044/v1" @default.
• W3136306228 hasPublicationYear "2021" @default.
• W3136306228 type Work @default.
• W3136306228 sameAs 3136306228 @default.
• W3136306228 citedByCount "1" @default.
• W3136306228 countsByYear W31363062282022 @default.
• W3136306228 crossrefType "posted-content" @default.
• W3136306228 hasAuthorship W3136306228A5016820076 @default.
• W3136306228 hasAuthorship W3136306228A5038407555 @default.
• W3136306228 hasAuthorship W3136306228A5045268311 @default.
• W3136306228 hasAuthorship W3136306228A5054528305 @default.
• W3136306228 hasAuthorship W3136306228A5078713137 @default.
• W3136306228 hasBestOaLocation W31363062281 @default.
• W3136306228 hasConcept C104317684 @default.
• W3136306228 hasConcept C121608353 @default.
• W3136306228 hasConcept C127561419 @default.
• W3136306228 hasConcept C140173407 @default.
• W3136306228 hasConcept C145059251 @default.
• W3136306228 hasConcept C150194340 @default.
• W3136306228 hasConcept C190727270 @default.
• W3136306228 hasConcept C2779013556 @default.
• W3136306228 hasConcept C41091548 @default.
• W3136306228 hasConcept C502942594 @default.
• W3136306228 hasConcept C530470458 @default.
• W3136306228 hasConcept C54355233 @default.
• W3136306228 hasConcept C86803240 @default.
• W3136306228 hasConceptScore W3136306228C104317684 @default.
• W3136306228 hasConceptScore W3136306228C121608353 @default.
• W3136306228 hasConceptScore W3136306228C127561419 @default.
• W3136306228 hasConceptScore W3136306228C140173407 @default.
• W3136306228 hasConceptScore W3136306228C145059251 @default.
• W3136306228 hasConceptScore W3136306228C150194340 @default.
• W3136306228 hasConceptScore W3136306228C190727270 @default.
• W3136306228 hasConceptScore W3136306228C2779013556 @default.
• W3136306228 hasConceptScore W3136306228C41091548 @default.
• W3136306228 hasConceptScore W3136306228C502942594 @default.
• W3136306228 hasConceptScore W3136306228C530470458 @default.
• W3136306228 hasConceptScore W3136306228C54355233 @default.
• W3136306228 hasConceptScore W3136306228C86803240 @default.
• W3136306228 hasLocation W31363062281 @default.
• W3136306228 hasOpenAccess W3136306228 @default.
• W3136306228 hasPrimaryLocation W31363062281 @default.
• W3136306228 hasRelatedWork W1677557982 @default.
• W3136306228 hasRelatedWork W1971238663 @default.
• W3136306228 hasRelatedWork W1975859778 @default.
• W3136306228 hasRelatedWork W2037966798 @default.
• W3136306228 hasRelatedWork W2118208642 @default.
• W3136306228 hasRelatedWork W2412162358 @default.
• W3136306228 hasRelatedWork W2772499952 @default.
• W3136306228 hasRelatedWork W2906330508 @default.
• W3136306228 hasRelatedWork W2924608116 @default.
• W3136306228 hasRelatedWork W3197311145 @default.
• W3136306228 isParatext "false" @default.
• W3136306228 isRetracted "false" @default.
• W3136306228 magId "3136306228" @default.
• W3136306228 workType "article" @default.